Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 43 | 39 | 35 | 35 | 28 |
| Accounts receivable | -79 | 161 | -83 | -41 | -56 |
| Other Working Capital | 2 | 89 | -91 | 42 | -37 |
| Other Operating Activity | -1,355 | -1,338 | -1,028 | -1,192 | -875 |
| Operating Cash Flow | $-1,388 | $-1,049 | $-1,166 | $-1,155 | $-940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -6 | -10 | -15 | -12 |
| Purchase Sale Intangibles | -98 | -181 | -123 | -78 | -104 |
| Investing Cash Flow | $-109 | $-187 | $-133 | $-93 | $-116 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -10 | -18 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 1,188 | 0 | 1,344 | 2,188 |
| Other Financing Activity | 658 | 398 | 519 | 0 | 0 |
| Financing Cash Flow | $648 | $1,568 | $519 | $1,344 | $2,188 |
| Beginning Cash Position | 966 | 634 | 1,415 | 1,319 | 188 |
| End Cash Position | 116 | 966 | 634 | 1,415 | 1,319 |
| Net Cash Flow | $-850 | $332 | $-781 | $96 | $1,132 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,388 | -1,049 | -1,166 | -1,155 | -940 |
| Capital Expenditure | -109 | -187 | -133 | -93 | -116 |
| Free Cash Flow | -1,498 | -1,236 | -1,300 | -1,249 | -1,057 |